Avidity Partners Management as of June 30, 2026
Portfolio Holdings for Avidity Partners Management
Avidity Partners Management holds 45 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Dianthus Therapeutics (DNTH) | 32.8 | $205M | 2.1M | 97.48 | |
| Cg Oncology (CGON) | 15.9 | $99M | 1.4M | 71.05 | |
| Oruka Therapeutics (ORKA) | 11.6 | $72M | 760k | 95.17 | |
| Jade Biosciences Com New (JBIO) | 6.1 | $38M | 1.7M | 22.22 | |
| Enliven Therapeutics (ELVN) | 4.5 | $28M | 550k | 50.75 | |
| Perspective Therapeutics Com New (CATX) | 3.4 | $22M | 6.3M | 3.41 | |
| Aktis Oncology (AKTS) | 2.5 | $16M | 484k | 32.23 | |
| Palvella Therapeutics Inc Ne (PVLA) | 1.7 | $11M | 70k | 152.82 | |
| Mobia Med Common Stock | 1.7 | $11M | 798k | 13.40 | |
| Repligen Corporation (RGEN) | 1.7 | $11M | 78k | 136.44 | |
| Immunic Com New (IMUX) | 1.6 | $10M | 670k | 15.37 | |
| Senseonics Hldgs (SENS) | 1.5 | $9.1M | 1.6M | 5.68 | |
| Karyopharm Therapeutics Com New (KPTI) | 1.4 | $9.0M | 925k | 9.77 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 1.1 | $6.8M | 200k | 33.88 | |
| Dex (DXCM) | 1.1 | $6.7M | 100k | 67.35 | |
| Tempus Ai Cl A (TEM) | 1.0 | $6.1M | 105k | 57.93 | |
| Medtronic SHS (MDT) | 0.9 | $5.5M | 70k | 78.23 | |
| Vir Biotechnology (VIR) | 0.8 | $5.3M | 519k | 10.19 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.8 | $5.3M | 98k | 53.67 | |
| Encompass Health Corp (EHC) | 0.7 | $4.2M | 42k | 101.08 | |
| Tenax Therapeutics Com New (TENX) | 0.6 | $3.9M | 266k | 14.55 | |
| Nuvectis Pharma (NVCT) | 0.6 | $3.7M | 200k | 18.39 | |
| Insulet Corporation (PODD) | 0.6 | $3.7M | 24k | 152.25 | |
| Boston Scientific Corporation (BSX) | 0.5 | $3.4M | 80k | 42.68 | |
| Satellos Bioscience (MSLE) | 0.5 | $3.0M | 388k | 7.78 | |
| Alamar Biosciences Common Stock | 0.5 | $3.0M | 110k | 27.09 | |
| Context Therapeutics (CNTX) | 0.4 | $2.8M | 5.0M | 0.55 | |
| Gilead Sciences (GILD) | 0.4 | $2.5M | 20k | 126.34 | |
| Charles River Laboratories (CRL) | 0.4 | $2.3M | 10k | 226.79 | |
| Phathom Pharmaceuticals (PHAT) | 0.3 | $2.2M | 200k | 10.85 | |
| Avalyn Pharmaceuticals Com Shs | 0.3 | $2.0M | 60k | 32.92 | |
| Kailera Therapeutics Common Stock | 0.3 | $1.8M | 80k | 22.03 | |
| Genmab A/s Sponsored Ads (GMAB) | 0.2 | $1.4M | 50k | 27.47 | |
| Intellia Therapeutics (NTLA) | 0.2 | $1.3M | 75k | 16.92 | |
| Corvus Pharmaceuticals (CRVS) | 0.2 | $1.2M | 80k | 14.94 | |
| Oddity Tech Shs Cl A (ODD) | 0.2 | $1.1M | 70k | 15.13 | |
| Scynexis | 0.2 | $1.1M | 260k | 4.07 | |
| Evommune Com Shs (EVMN) | 0.2 | $997k | 75k | 13.29 | |
| Abbott Laboratories (ABT) | 0.1 | $907k | 10k | 90.74 | |
| Bridgebio Pharma (BBIO) | 0.1 | $745k | 10k | 74.48 | |
| Peloton Interactive Cl A Com (PTON) | 0.1 | $591k | 100k | 5.91 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 0.1 | $433k | 15k | 28.88 | |
| Bridgebio Oncology Therapeut Com New (BBOT) | 0.1 | $334k | 44k | 7.62 | |
| Savara (SVRA) | 0.0 | $308k | 50k | 6.16 | |
| Trevi Therapeutics (TRVI) | 0.0 | $124k | 6.7k | 18.65 |
